TY  - JOUR
PY  - 2013//
TI  - A model list of high risk drugs
JO  - Anales de Pediatria
A1  - Cotrina Luque, J.
A1  - Guerrero Aznar, M. D.
A1  - Alvarez Del Vayo Benito, C.
A1  - Jimenez Mesa, E.
A1  - Guzman Laura, K. P.
A1  - Fernández Fernández, L.
SP  - 360
EP  - 366
VL  - 79
IS  - 6
N2  - INTRODUCTION: "High-risk drugs" are those that have a very high "risk" of causing death or serious injury if an error occurs during its use. The Institute for Safe Medication Practices (ISMP) has prepared a high-risk drugs list applicable to the general population (with no differences between the pediatric and adult population). Thus, there is a lack of information for the pediatric population. The main objective of this work is to develop a high-risk drug list adapted to the neonatal or pediatric population as a reference model for the pediatric hospital health workforce. MATERIAL AND METHODS: We made a literature search in May 2012 to identify any published lists or references in relation to pediatric and/or neonatal high-risk drugs. RESULTS: A total of 15 studies were found, from which 9 were selected. A model list was developed mainly based on the ISMP one, adding strongly perceived pediatric risk drugs and removing those where the pediatric use was anecdotal. CONCLUSIONS: There is no published list that suits pediatric risk management. The list of pediatric and neonatal high-risk drugs presented here could be a "reference list of high-risk drugs " for pediatric hospitals. Using this list and training will help to prevent medication errors in each drug supply chain (prescribing, transcribing, dispensing and administration).<p />  <p>Language: es</p>
LA  - es
SN  - 1695-4033
UR  - http://dx.doi.org/10.1016/j.anpedi.2013.04.026
ID  - ref1
ER  -